查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1999058

專用PACS市場：依模式、組件、最終用戶和部署方式分類－2026-2032年全球市場預測

Specialty PACS Market by Modality, Component, End User, Deployment - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 181 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2025 年，專用 PACS 市場價值將達到 53.1 億美元，到 2026 年將成長到 57.7 億美元，到 2032 年將達到 97.2 億美元，複合年成長率為 9.01%。

主要市場統計數據
基準年 2025 53.1億美元
預計年份：2026年 57.7億美元
預測年份：2032年 97.2億美元
複合年成長率 (%) 9.01%

詳細概述了臨床需求、互通性期望和營運壓力如何將專用 PACS 的市場結構轉變為以結果為導向的基礎設施。

本文概述了專業影像歸檔和通訊系統 (PACS) 的現狀，闡述了臨床需求、技術創新和營運壓力之間的相互作用如何影響買賣雙方的行為。放射科、循環系統、牙科、整形外科和獸醫科的相關人員日益尋求能夠提高影像擷取效率、加快影像解讀流程並與更廣泛的臨床和管理生態系統整合的解決方案。隨著醫療服務模式的演變，影像基礎設施需要超越傳統的儲存方式，在所有醫療環境中實現安全、即時的存取和長期的影像連續性。

雲端原生技術的應用、人工智慧整合、對互通性日益成長的需求以及網路安全的增強，正在如何重新定義整個影像生態系統中醫療服務提供者和供應商的策略？

多項變革正在重塑醫療服務提供者和PACS供應商的策略重點。首先，雲端遷移已從「可選項」轉變為「核心」必需品。各機構現在正在權衡公共雲端雲和私有雲端的柔軟性與本地環境的可控性和延遲問題。這種轉變與人工智慧驅動的影像工作流程的興起密切相關，這些工作流程需要可擴展的運算能力和整合的數據管道來實現分診、量化和品質保證演算法。

了解 2025 年關稅變化對成像技術採購、供應鏈韌性和採購決策矩陣的多方面影響。

2025年貿易政策變化和關稅調整的累積影響，為成像技術​​供應鏈中的供應商、廠商和經銷商帶來了複雜的營運和採購挑戰。對於伺服器、工作站和儲存陣列等設備密集型組件而言，不斷上漲的到貨成本正在影響採購時機、供應商選擇和總體擁有成本 (TCO) 的運算。對於依賴全球零件採購的企業而言，前置作業時間和清關的不確定性進一步凸顯了庫存緩衝、供應商多元化以及加強交貨日期合約保障的必要性。

深入了解最終用戶類型、雲端與本地部署選擇、特定模式需求以及組件級產品組合如何決定差異化產品和上市時間策略。

細分市場的趨勢揭示了供應商和醫療系統在調整產品策略以滿足買家需求時應考慮的價值來源和部署模式。不同終端使用者（診所、醫院和影像中心）的決策標準各不相同。診所通常優先考慮易用性、低成本和快速部署，而醫院則要求企業級整合、可擴展性和符合內部IT政策。影像中心優先考慮處理能力、不同模式之間的互通性和商業性柔軟性。在醫院內部，公立和私立機構之間的區別進一步影響採購計劃和供應商合作模式；私立醫院傾向於追求更快的採購週期和客製化化服務契約，而公立醫院則在正式的競標程序和預算限制下運作。

北美、歐洲、中東和非洲以及亞太地區的區域趨勢和戰略需求正在影響成像解決方案的採用、部署和夥伴關係模式。

區域趨勢持續影響著美洲、歐洲、中東和非洲以及亞太地區的市場採納管道和商業性模式，每個地區都反映了其獨特的監管、經濟和醫療服務提供的細微差別。在美洲，買家高度重視整合的臨床工作流程、合規性以及支援遠端影像判讀和多站點整合的功能，其中私人醫療系統和大規模診斷連鎖機構是先進PACS功能的主要採用者。相較之下，歐洲、中東和非洲的市場格局較為分散，由於各國採購法規、公共醫療系統結構和IT成熟度各不相同，需求也呈現多樣化的特徵。在這些市場，供應商正透過利用在地化夥伴關係關係、強大的資料居住選項和靈活的商業模式來滿足公共競標和私人醫療機構的需求。

供應商如何利用模組化平台、夥伴關係和不斷發展的經營模式，在成像生態系統中平衡技術領先地位和營運可靠性？

專用PACS市場的競爭圍繞著三大策略軸：技術差異化、確保互通性和卓越服務。大型成熟供應商正日益將先進的視覺化功能、人工智慧輔助工具和企業級支援服務捆綁在一起，以維繫與大規模醫療系統的合約。同時，中小型專業供應商和創新Start-Ups則透過提供細分領域的臨床功能、快速部署和模組化部署選項來競爭。許多公司正在採用平台化方法，整合儲存管理、工作流程編配和分析模組，以提高客戶留存率並創造提升銷售機會。

為供應商和醫療保健領導者提供切實可行的策略步驟，以增強產品差異化、供應鏈韌性和在各種部署環境中的臨床應用。

產業領導企業可以透過專注於技術、商業性協同和營運準備，即時採取策略措施來增強自身競爭優勢並改善客戶體驗。首先，投資於模組化架構，該架構應同時支援私有雲端雲和公共雲端選項，並支援滿足不同延遲、安全性和資料居住要求的混合部署。其次，透過優先採用開放標準和強大的API，並簡化與電子健康記錄、設備供應商和第三方分析工具的整合，來減少採購和部署過程中的摩擦。第三，為人工智慧和進階視覺化功能建立清晰的臨床檢驗流程。展現可衡量的工作流程優勢和診斷效果，可以加速懷疑的臨床相關人員的接受度。

我們採用了嚴謹的混合方法研究途徑，結合了對臨床醫生和供應商的訪談、產品評估、標準分析和檢驗，以確保研究結果的穩健性和檢驗。

本調查方法透過整合一手和二手研究，確保研究結果的穩健性、可重複性以及與相關人員實際情況的一致性。一手研究包括對臨床醫生、IT主管、採購專家和供應商高管進行結構化訪談，以收集關於技術需求、採購障礙、實施經驗和服務期望的第一手觀點。這些定性見解輔以產品層面的評估以及對供應商文件、技術白皮書和公開監管文件的現場審查，以檢驗功能集和整合能力。

這個整體結論概述了為什麼整合成熟度、檢驗的臨床結果和穩健的經營模式對於成像系統的成功現代化至關重要。

總之，專用PACS系統正處於一個轉折點，技術能力、整合成熟度和商業性柔軟性將決定哪些解決方案能夠帶來永續的臨床和營運價值。雲端和混合部署模式、人工智慧驅動的工作流程改進以及對互通性和網路安全的日益重視，不再是可選項，而是現代影像專案的必備條件。能夠將模組化產品設計、基於服務的經營模式和強大的供應鏈結合的供應商，最能滿足診所、醫院和影像中心等各類客戶的多樣化需求。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席主管觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 工業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

第8章：專用PACS市場：依模式分類

  • 循環系統
  • 牙科
  • 整形外科
  • 放射科
  • 獸醫學

第9章：專用PACS市場：依組件分類

  • 硬體
    • 伺服器
    • 工作站
  • 服務
    • 執行
    • 維護和支援
  • 軟體
    • 儲存管理
    • 工作流程管理

第10章：專用PACS市場：依最終用戶分類

  • 診所
  • 醫院
    • 私人的
    • 民眾
  • 影像中心

第11章：專用PACS市場：依部署類型分類

  • 雲
    • 私有雲端
    • 公共雲端
  • 現場

第12章：專用PACS市場：依地區分類

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第13章：專用PACS市場：依組別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第14章 專用PACS市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第15章：美國專用PACS市場

第16章：中國的專用PACS市場

第17章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • Agfa-Gevaert NV
  • Carestream Health, Inc.
  • Change Healthcare LLC
  • Fujifilm Holdings Corporation
  • GE HealthCare Technologies Inc.
  • Hyland Software Inc.
  • Intelerad Medical Systems, Inc.
  • Konica Minolta, Inc.
  • Koninklijke Philips NV
  • Oracle Corporation
  • Sectra AB
  • Siemens Healthineers AG
Product Code: MRR-E370886763A2

The Specialty PACS Market was valued at USD 5.31 billion in 2025 and is projected to grow to USD 5.77 billion in 2026, with a CAGR of 9.01%, reaching USD 9.72 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 5.31 billion
Estimated Year [2026] USD 5.77 billion
Forecast Year [2032] USD 9.72 billion
CAGR (%) 9.01%

A thorough overview of how clinical demand, interoperability expectations, and operational pressures are reshaping the specialty PACS landscape into an outcomes-driven infrastructure

The introduction frames the specialty picture archiving and communication systems (PACS) landscape by outlining the confluence of clinical demand, technological innovation, and operational pressures that define buyer and supplier behavior. Radiology, cardiology, dental, orthopedic, and veterinary stakeholders increasingly require solutions that streamline image capture, accelerate interpretation workflows, and integrate with broader clinical and administrative ecosystems. As care delivery models evolve, imaging infrastructure must move beyond traditional storage to enable secure, real-time access and longitudinal image continuity across care settings.

Concurrently, vendors face higher expectations for interoperability, clinical decision support, and measurable contributions to throughput and diagnostic confidence. Given the diversity of deployment environments spanning clinics, hospitals, and imaging centers, design choices that prioritize adaptability, usability, and security become differentiators. The introduction thus sets the stage for a deeper assessment of drivers shaping purchasing behavior, supplier strategies, and the operational challenges that health systems and independent providers must address to realize the value of imaging investments.

How cloud-native evolution, AI integration, heightened interoperability demands, and strengthened cybersecurity are collectively redefining provider and vendor strategies across imaging ecosystems

Several transformative shifts are remapping the strategic priorities of healthcare providers and PACS suppliers alike. First, cloud migration has moved from optional to core; organizations now weigh the flexibility of public and private cloud options against on-premise control and latency concerns. This shift is tightly coupled with the rise of AI-enabled imaging workflows, which demand scalable compute and integrated data pipelines to operationalize algorithms for triage, quantitation, and quality assurance.

Second, interoperability and standards-driven integration have become essential for multi-vendor environments; providers prioritize systems that support industry standards and seamless exchange among electronic health records, modality vendors, and analytics platforms. Third, cybersecurity and data governance have intensified as priorities, prompting investments in encryption, identity management, and secure access models to protect sensitive imaging datasets while enabling authorized remote access. Fourth, economic and operational pressures such as staff shortages and throughput targets are prompting automation and workflow orchestration to reduce repetitive tasks and accelerate reporting. Lastly, distribution channels and partnership models are evolving: vendors are expanding managed services, outcome-based contracts, and cloud-native offerings to align commercial models with provider risk appetites and resource constraints. Taken together, these shifts create an environment where adaptability, clinical integration, and trustworthiness determine long-term success.

Understanding the multifaceted repercussions of 2025 tariff changes on imaging technology procurement, supply chain resilience, and procurement decision matrices

The cumulative impact of trade policy changes and tariff adjustments in 2025 has introduced a complex set of operational and procurement considerations for providers, vendors, and distributors engaged in imaging technology supply chains. Equipment-intensive components such as servers, workstations, and storage arrays have seen upward pressure on landed costs, which in turn influences procurement timing, vendor selection, and the total cost of ownership calculus. For organizations that rely on global component sourcing, lead-time volatility and customs processing variability have emphasized the need for inventory buffers, diversified supplier bases, and stronger contractual protections around delivery windows.

Moreover, the tariff environment has accelerated supplier strategies to localize production, qualify alternate components, or redesign packaging and logistics to reduce duty exposure. As a result, procurement teams increasingly evaluate offers not only on sticker price but on supply chain resilience, after-sales support, and upgrade pathways that minimize exposure to future trade shifts. Importantly, regulatory and reimbursement frameworks interact with tariff impacts because higher upfront hardware costs can influence the attractiveness of cloud or managed service alternatives where capital expenditures are converted into operational spend. In short, tariffs have amplified the importance of supply chain visibility, contractual flexibility, and scenario planning when assessing imaging technology investments.

Actionable insights on how end user types, cloud versus on-premise choices, modality-specific needs, and component-level portfolios dictate differentiated product and go-to-market strategies

Segment-level dynamics reveal distinct value drivers and adoption patterns that suppliers and health systems must consider when aligning product strategy with buyer needs. Based on End User, decision criteria diverge between clinics, hospitals, and imaging centers; clinics typically prioritize ease of use, low overhead, and rapid deployment, whereas hospitals demand enterprise-grade integration, scalability, and compliance with internal IT policies. Imaging centers emphasize throughput, modality interoperability, and commercial flexibility. Within hospitals the distinction between private and public institutions further shapes procurement timelines and vendor engagement models, with private hospitals often pursuing faster procurement cycles and tailored service agreements while public hospitals operate within formal tendering and budgetary constraints.

Based on Deployment, the trade-offs between Cloud and On-Premise persist, with many organizations choosing hybrid approaches that combine the agility of cloud platforms with on-premise control for latency-sensitive workloads. Cloud adoption decisions are nuanced by the choice between Private Cloud and Public Cloud, as both offer different balances of security, performance, and cost transparency. Based on Modality, clinical specialties such as Cardiology, Dental, Orthopedic, Radiology, and Veterinary place unique demands on PACS capabilities; cardiology and radiology require advanced visualization and structured reporting, dental workflows prioritize high-resolution localized imaging and simplified archiving, orthopedic use cases demand integration with pre-operative planning tools, and veterinary practices need flexible licensing models and cross-species imaging templates. Based on Component, supplier portfolios must account for Hardware, Services, and Software. Hardware considerations focus on Servers and Workstations engineered for imaging throughput and resilience. Services span Implementation and Maintenance And Support, where efficient onboarding and SLA-driven support reduce downtime risk. Software capabilities concentrate on Storage Management and Workflow Management, with emphasis on scalable storage architectures and workflow orchestration that accelerates case routing, reporting, and auditability.

Regional dynamics and strategic imperatives across the Americas, Europe Middle East & Africa, and Asia-Pacific that influence adoption, deployment, and partnership models for imaging solutions

Regional dynamics continue to shape adoption pathways and commercial approaches across the Americas, Europe, Middle East & Africa, and Asia-Pacific, with each geography reflecting unique regulatory, economic, and care delivery nuances. In the Americas, buyers place high value on integrated clinical workflows, regulatory compliance, and capabilities that support remote reading and multi-site consolidation; private health systems and large diagnostic chains are central adopters of advanced PACS functionalities. By contrast, Europe, Middle East & Africa exhibits a fragmented landscape where national procurement rules, public health system structures, and varying levels of IT maturity create a patchwork of requirements. In these markets, vendors benefit from localized partnerships, strong data residency options, and flexible commercial models to navigate public tenders and private provider needs.

Meanwhile, Asia-Pacific demonstrates rapid technological adoption in urban centers and a strong appetite for cloud-enabled services and AI-augmented workflows, though uneven infrastructure and local regulatory regimes necessitate tailored deployment strategies. Across regions, reimbursement models, workforce availability, and the maturity of health information exchanges influence whether organizations prioritize on-premise control or cloud-based scalability. Transitioning between these regional environments requires vendors and purchasers to align product roadmaps with local compliance, language support, and channel capabilities while also planning for cross-border interoperability and data governance.

How vendors are leveraging modular platforms, partnerships, and evolving commercial models to balance technological leadership with operational reliability in imaging ecosystems

Competitive behavior in the specialty PACS arena centers on three strategic axes: technological differentiation, interoperability commitments, and service excellence. Leading established vendors increasingly bundle advanced visualization, AI-assisted tools, and enterprise-grade support to retain large health system contracts, while smaller specialist vendors and innovative startups compete by offering niche clinical functionality, rapid implementation, and modular deployment options. Many companies pursue a platform approach that integrates storage management, workflow orchestration, and analytics modules to increase stickiness and create upsell pathways.

Partnerships have become a primary mechanism to extend capabilities quickly; imaging vendors collaborate with cloud providers, AI developers, and system integrators to accelerate time-to-value and expand addressable use cases. Commercial models are also diversifying: aside from traditional perpetual licensing and maintenance, subscription, outcome-based, and managed service offerings create alternatives that align vendor incentives with operational performance. In this context, procurement teams should evaluate vendor roadmaps, interoperability commitments, evidence of clinical validation, and post-deployment service models. For organizations seeking to modernize imaging infrastructure, a careful vendor selection process that balances innovation with proven support mechanisms will be essential to mitigate implementation risk and ensure long-term operability.

Practical strategic steps for vendors and healthcare leaders to strengthen product differentiation, supply chain resilience, and clinical adoption across diverse deployment environments

Industry leaders can take immediate strategic actions to strengthen competitive positioning and enhance customer outcomes by addressing technology, commercial alignment, and operational readiness. First, invest in modular architectures that support both private cloud and public cloud options while enabling hybrid deployments to meet diverse latency, security, and data residency needs. Second, prioritize open standards and robust APIs to simplify integration with electronic health records, modality vendors, and third-party analytics, thereby reducing friction during procurement and deployment. Third, develop clear clinical validation pathways for AI and advanced visualization features; demonstrating measurable workflow benefits and diagnostic impact will accelerate adoption among skeptical clinical stakeholders.

Fourth, reinforce supply chain resilience through supplier diversification, local assembly options, and contractual provisions that protect delivery timelines amidst trade policy shifts. Fifth, expand service portfolios to include managed services, outcome-linked agreements, and modular support tiers that address the needs of clinics, hospitals, and imaging centers. Finally, cultivate partnerships with health systems and clinical champions to co-develop workflow optimizations and training programs that increase clinician confidence and successful uptake. Implementing these recommendations will require cross-functional coordination among product, clinical affairs, and commercial teams, but the payoff will be stronger differentiation and lower total implementation risk for customers.

A rigorous mixed-methods research approach combining clinician and vendor interviews, product assessments, standards analysis, and triangulation to ensure robust and validated findings

The research methodology blends primary and secondary approaches to ensure findings are robust, reproducible, and aligned with stakeholder realities. Primary research included structured interviews with clinicians, IT leaders, procurement specialists, and vendor executives to capture firsthand perspectives on technology requirements, procurement barriers, deployment experiences, and service expectations. These qualitative insights were supplemented by product-level assessments and hands-on reviews of vendor documentation, technical whitepapers, and publicly available regulatory filings to validate feature sets and integration capabilities.

Secondary research encompassed analysis of policy documents, standards organizations, and published clinical validation studies to contextualize regulatory and scientific drivers. Data triangulation techniques were applied to reconcile divergent inputs, and cross-validation with independent domain experts helped refine conclusions and identify potential blind spots. The methodology also incorporated scenario analysis to evaluate supply chain and policy sensitivities. Limitations include variability in regional reporting standards and the dynamic nature of software releases; to mitigate these constraints, the study emphasizes documented capabilities and validated customer experiences rather than speculative product roadmaps.

A synthesized conclusion outlining why integration maturity, validated clinical outcomes, and resilient commercial models are essential for successful imaging modernization

In conclusion, the specialty PACS landscape stands at an inflection point where technology capability, integration maturity, and commercial flexibility determine which solutions deliver sustained clinical and operational value. Cloud and hybrid deployment patterns, AI-enabled workflow augmentation, and heightened emphasis on interoperability and cybersecurity are no longer optional features but foundational requirements for modern imaging programs. Suppliers that align modular product design with service-based commercial models and resilient supply chains will be best positioned to meet diverse customer needs across clinics, hospitals, and imaging centers.

For healthcare organizations, the imperative is to adopt procurement and implementation strategies that prioritize integration, validated clinical outcomes, and supplier accountability. Transitioning to next-generation imaging infrastructure requires careful vendor selection, staged rollout plans, and investment in clinician training and change management. By following evidence-based decision criteria and preparing for policy and supply chain contingencies, both buyers and sellers can accelerate value realization and support improved diagnostic workflows and patient outcomes.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Specialty PACS Market, by Modality

  • 8.1. Cardiology
  • 8.2. Dental
  • 8.3. Orthopedic
  • 8.4. Radiology
  • 8.5. Veterinary

9. Specialty PACS Market, by Component

  • 9.1. Hardware
    • 9.1.1. Servers
    • 9.1.2. Workstations
  • 9.2. Services
    • 9.2.1. Implementation
    • 9.2.2. Maintenance And Support
  • 9.3. Software
    • 9.3.1. Storage Management
    • 9.3.2. Workflow Management

10. Specialty PACS Market, by End User

  • 10.1. Clinics
  • 10.2. Hospitals
    • 10.2.1. Private
    • 10.2.2. Public
  • 10.3. Imaging Centers

11. Specialty PACS Market, by Deployment

  • 11.1. Cloud
    • 11.1.1. Private Cloud
    • 11.1.2. Public Cloud
  • 11.2. On-Premise

12. Specialty PACS Market, by Region

  • 12.1. Americas
    • 12.1.1. North America
    • 12.1.2. Latin America
  • 12.2. Europe, Middle East & Africa
    • 12.2.1. Europe
    • 12.2.2. Middle East
    • 12.2.3. Africa
  • 12.3. Asia-Pacific

13. Specialty PACS Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Specialty PACS Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. United States Specialty PACS Market

16. China Specialty PACS Market

17. Competitive Landscape

  • 17.1. Market Concentration Analysis, 2025
    • 17.1.1. Concentration Ratio (CR)
    • 17.1.2. Herfindahl Hirschman Index (HHI)
  • 17.2. Recent Developments & Impact Analysis, 2025
  • 17.3. Product Portfolio Analysis, 2025
  • 17.4. Benchmarking Analysis, 2025
  • 17.5. Agfa-Gevaert N.V.
  • 17.6. Carestream Health, Inc.
  • 17.7. Change Healthcare LLC
  • 17.8. Fujifilm Holdings Corporation
  • 17.9. GE HealthCare Technologies Inc.
  • 17.10. Hyland Software Inc.
  • 17.11. Intelerad Medical Systems, Inc.
  • 17.12. Konica Minolta, Inc.
  • 17.13. Koninklijke Philips N.V.
  • 17.14. Oracle Corporation
  • 17.15. Sectra AB
  • 17.16. Siemens Healthineers AG

LIST OF FIGURES

  • FIGURE 1. GLOBAL SPECIALTY PACS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL SPECIALTY PACS MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL SPECIALTY PACS MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL SPECIALTY PACS MARKET SIZE, BY MODALITY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL SPECIALTY PACS MARKET SIZE, BY COMPONENT, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL SPECIALTY PACS MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL SPECIALTY PACS MARKET SIZE, BY DEPLOYMENT, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL SPECIALTY PACS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL SPECIALTY PACS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL SPECIALTY PACS MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. UNITED STATES SPECIALTY PACS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 12. CHINA SPECIALTY PACS MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL SPECIALTY PACS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL SPECIALTY PACS MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL SPECIALTY PACS MARKET SIZE, BY CARDIOLOGY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL SPECIALTY PACS MARKET SIZE, BY CARDIOLOGY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL SPECIALTY PACS MARKET SIZE, BY CARDIOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL SPECIALTY PACS MARKET SIZE, BY DENTAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL SPECIALTY PACS MARKET SIZE, BY DENTAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL SPECIALTY PACS MARKET SIZE, BY DENTAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL SPECIALTY PACS MARKET SIZE, BY ORTHOPEDIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL SPECIALTY PACS MARKET SIZE, BY ORTHOPEDIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL SPECIALTY PACS MARKET SIZE, BY ORTHOPEDIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL SPECIALTY PACS MARKET SIZE, BY RADIOLOGY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL SPECIALTY PACS MARKET SIZE, BY RADIOLOGY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL SPECIALTY PACS MARKET SIZE, BY RADIOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL SPECIALTY PACS MARKET SIZE, BY VETERINARY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL SPECIALTY PACS MARKET SIZE, BY VETERINARY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL SPECIALTY PACS MARKET SIZE, BY VETERINARY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL SPECIALTY PACS MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL SPECIALTY PACS MARKET SIZE, BY HARDWARE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL SPECIALTY PACS MARKET SIZE, BY HARDWARE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL SPECIALTY PACS MARKET SIZE, BY HARDWARE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL SPECIALTY PACS MARKET SIZE, BY HARDWARE, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL SPECIALTY PACS MARKET SIZE, BY SERVERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL SPECIALTY PACS MARKET SIZE, BY SERVERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL SPECIALTY PACS MARKET SIZE, BY SERVERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL SPECIALTY PACS MARKET SIZE, BY WORKSTATIONS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL SPECIALTY PACS MARKET SIZE, BY WORKSTATIONS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL SPECIALTY PACS MARKET SIZE, BY WORKSTATIONS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL SPECIALTY PACS MARKET SIZE, BY SERVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL SPECIALTY PACS MARKET SIZE, BY SERVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL SPECIALTY PACS MARKET SIZE, BY SERVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL SPECIALTY PACS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL SPECIALTY PACS MARKET SIZE, BY IMPLEMENTATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL SPECIALTY PACS MARKET SIZE, BY IMPLEMENTATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL SPECIALTY PACS MARKET SIZE, BY IMPLEMENTATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL SPECIALTY PACS MARKET SIZE, BY MAINTENANCE AND SUPPORT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL SPECIALTY PACS MARKET SIZE, BY MAINTENANCE AND SUPPORT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL SPECIALTY PACS MARKET SIZE, BY MAINTENANCE AND SUPPORT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL SPECIALTY PACS MARKET SIZE, BY SOFTWARE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL SPECIALTY PACS MARKET SIZE, BY SOFTWARE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL SPECIALTY PACS MARKET SIZE, BY SOFTWARE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL SPECIALTY PACS MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL SPECIALTY PACS MARKET SIZE, BY STORAGE MANAGEMENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL SPECIALTY PACS MARKET SIZE, BY STORAGE MANAGEMENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL SPECIALTY PACS MARKET SIZE, BY STORAGE MANAGEMENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL SPECIALTY PACS MARKET SIZE, BY WORKFLOW MANAGEMENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL SPECIALTY PACS MARKET SIZE, BY WORKFLOW MANAGEMENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL SPECIALTY PACS MARKET SIZE, BY WORKFLOW MANAGEMENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL SPECIALTY PACS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL SPECIALTY PACS MARKET SIZE, BY CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL SPECIALTY PACS MARKET SIZE, BY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL SPECIALTY PACS MARKET SIZE, BY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL SPECIALTY PACS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL SPECIALTY PACS MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL SPECIALTY PACS MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL SPECIALTY PACS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL SPECIALTY PACS MARKET SIZE, BY PRIVATE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL SPECIALTY PACS MARKET SIZE, BY PRIVATE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL SPECIALTY PACS MARKET SIZE, BY PRIVATE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL SPECIALTY PACS MARKET SIZE, BY PUBLIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL SPECIALTY PACS MARKET SIZE, BY PUBLIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL SPECIALTY PACS MARKET SIZE, BY PUBLIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL SPECIALTY PACS MARKET SIZE, BY IMAGING CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL SPECIALTY PACS MARKET SIZE, BY IMAGING CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL SPECIALTY PACS MARKET SIZE, BY IMAGING CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL SPECIALTY PACS MARKET SIZE, BY DEPLOYMENT, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL SPECIALTY PACS MARKET SIZE, BY CLOUD, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL SPECIALTY PACS MARKET SIZE, BY CLOUD, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL SPECIALTY PACS MARKET SIZE, BY CLOUD, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL SPECIALTY PACS MARKET SIZE, BY CLOUD, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL SPECIALTY PACS MARKET SIZE, BY PRIVATE CLOUD, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL SPECIALTY PACS MARKET SIZE, BY PRIVATE CLOUD, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL SPECIALTY PACS MARKET SIZE, BY PRIVATE CLOUD, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL SPECIALTY PACS MARKET SIZE, BY PUBLIC CLOUD, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL SPECIALTY PACS MARKET SIZE, BY PUBLIC CLOUD, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL SPECIALTY PACS MARKET SIZE, BY PUBLIC CLOUD, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL SPECIALTY PACS MARKET SIZE, BY ON-PREMISE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL SPECIALTY PACS MARKET SIZE, BY ON-PREMISE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL SPECIALTY PACS MARKET SIZE, BY ON-PREMISE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL SPECIALTY PACS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 81. AMERICAS SPECIALTY PACS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 82. AMERICAS SPECIALTY PACS MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 83. AMERICAS SPECIALTY PACS MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 84. AMERICAS SPECIALTY PACS MARKET SIZE, BY HARDWARE, 2018-2032 (USD MILLION)
  • TABLE 85. AMERICAS SPECIALTY PACS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 86. AMERICAS SPECIALTY PACS MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 87. AMERICAS SPECIALTY PACS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 88. AMERICAS SPECIALTY PACS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 89. AMERICAS SPECIALTY PACS MARKET SIZE, BY DEPLOYMENT, 2018-2032 (USD MILLION)
  • TABLE 90. AMERICAS SPECIALTY PACS MARKET SIZE, BY CLOUD, 2018-2032 (USD MILLION)
  • TABLE 91. NORTH AMERICA SPECIALTY PACS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 92. NORTH AMERICA SPECIALTY PACS MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 93. NORTH AMERICA SPECIALTY PACS MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 94. NORTH AMERICA SPECIALTY PACS MARKET SIZE, BY HARDWARE, 2018-2032 (USD MILLION)
  • TABLE 95. NORTH AMERICA SPECIALTY PACS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 96. NORTH AMERICA SPECIALTY PACS MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 97. NORTH AMERICA SPECIALTY PACS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 98. NORTH AMERICA SPECIALTY PACS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 99. NORTH AMERICA SPECIALTY PACS MARKET SIZE, BY DEPLOYMENT, 2018-2032 (USD MILLION)
  • TABLE 100. NORTH AMERICA SPECIALTY PACS MARKET SIZE, BY CLOUD, 2018-2032 (USD MILLION)
  • TABLE 101. LATIN AMERICA SPECIALTY PACS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 102. LATIN AMERICA SPECIALTY PACS MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 103. LATIN AMERICA SPECIALTY PACS MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 104. LATIN AMERICA SPECIALTY PACS MARKET SIZE, BY HARDWARE, 2018-2032 (USD MILLION)
  • TABLE 105. LATIN AMERICA SPECIALTY PACS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 106. LATIN AMERICA SPECIALTY PACS MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 107. LATIN AMERICA SPECIALTY PACS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 108. LATIN AMERICA SPECIALTY PACS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 109. LATIN AMERICA SPECIALTY PACS MARKET SIZE, BY DEPLOYMENT, 2018-2032 (USD MILLION)
  • TABLE 110. LATIN AMERICA SPECIALTY PACS MARKET SIZE, BY CLOUD, 2018-2032 (USD MILLION)
  • TABLE 111. EUROPE, MIDDLE EAST & AFRICA SPECIALTY PACS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 112. EUROPE, MIDDLE EAST & AFRICA SPECIALTY PACS MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 113. EUROPE, MIDDLE EAST & AFRICA SPECIALTY PACS MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 114. EUROPE, MIDDLE EAST & AFRICA SPECIALTY PACS MARKET SIZE, BY HARDWARE, 2018-2032 (USD MILLION)
  • TABLE 115. EUROPE, MIDDLE EAST & AFRICA SPECIALTY PACS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 116. EUROPE, MIDDLE EAST & AFRICA SPECIALTY PACS MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 117. EUROPE, MIDDLE EAST & AFRICA SPECIALTY PACS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 118. EUROPE, MIDDLE EAST & AFRICA SPECIALTY PACS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 119. EUROPE, MIDDLE EAST & AFRICA SPECIALTY PACS MARKET SIZE, BY DEPLOYMENT, 2018-2032 (USD MILLION)
  • TABLE 120. EUROPE, MIDDLE EAST & AFRICA SPECIALTY PACS MARKET SIZE, BY CLOUD, 2018-2032 (USD MILLION)
  • TABLE 121. EUROPE SPECIALTY PACS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 122. EUROPE SPECIALTY PACS MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 123. EUROPE SPECIALTY PACS MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 124. EUROPE SPECIALTY PACS MARKET SIZE, BY HARDWARE, 2018-2032 (USD MILLION)
  • TABLE 125. EUROPE SPECIALTY PACS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 126. EUROPE SPECIALTY PACS MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 127. EUROPE SPECIALTY PACS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 128. EUROPE SPECIALTY PACS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 129. EUROPE SPECIALTY PACS MARKET SIZE, BY DEPLOYMENT, 2018-2032 (USD MILLION)
  • TABLE 130. EUROPE SPECIALTY PACS MARKET SIZE, BY CLOUD, 2018-2032 (USD MILLION)
  • TABLE 131. MIDDLE EAST SPECIALTY PACS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 132. MIDDLE EAST SPECIALTY PACS MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 133. MIDDLE EAST SPECIALTY PACS MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 134. MIDDLE EAST SPECIALTY PACS MARKET SIZE, BY HARDWARE, 2018-2032 (USD MILLION)
  • TABLE 135. MIDDLE EAST SPECIALTY PACS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 136. MIDDLE EAST SPECIALTY PACS MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 137. MIDDLE EAST SPECIALTY PACS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 138. MIDDLE EAST SPECIALTY PACS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 139. MIDDLE EAST SPECIALTY PACS MARKET SIZE, BY DEPLOYMENT, 2018-2032 (USD MILLION)
  • TABLE 140. MIDDLE EAST SPECIALTY PACS MARKET SIZE, BY CLOUD, 2018-2032 (USD MILLION)
  • TABLE 141. AFRICA SPECIALTY PACS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 142. AFRICA SPECIALTY PACS MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 143. AFRICA SPECIALTY PACS MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 144. AFRICA SPECIALTY PACS MARKET SIZE, BY HARDWARE, 2018-2032 (USD MILLION)
  • TABLE 145. AFRICA SPECIALTY PACS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 146. AFRICA SPECIALTY PACS MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 147. AFRICA SPECIALTY PACS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 148. AFRICA SPECIALTY PACS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 149. AFRICA SPECIALTY PACS MARKET SIZE, BY DEPLOYMENT, 2018-2032 (USD MILLION)
  • TABLE 150. AFRICA SPECIALTY PACS MARKET SIZE, BY CLOUD, 2018-2032 (USD MILLION)
  • TABLE 151. ASIA-PACIFIC SPECIALTY PACS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 152. ASIA-PACIFIC SPECIALTY PACS MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 153. ASIA-PACIFIC SPECIALTY PACS MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 154. ASIA-PACIFIC SPECIALTY PACS MARKET SIZE, BY HARDWARE, 2018-2032 (USD MILLION)
  • TABLE 155. ASIA-PACIFIC SPECIALTY PACS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 156. ASIA-PACIFIC SPECIALTY PACS MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 157. ASIA-PACIFIC SPECIALTY PACS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 158. ASIA-PACIFIC SPECIALTY PACS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 159. ASIA-PACIFIC SPECIALTY PACS MARKET SIZE, BY DEPLOYMENT, 2018-2032 (USD MILLION)
  • TABLE 160. ASIA-PACIFIC SPECIALTY PACS MARKET SIZE, BY CLOUD, 2018-2032 (USD MILLION)
  • TABLE 161. GLOBAL SPECIALTY PACS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 162. ASEAN SPECIALTY PACS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 163. ASEAN SPECIALTY PACS MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 164. ASEAN SPECIALTY PACS MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 165. ASEAN SPECIALTY PACS MARKET SIZE, BY HARDWARE, 2018-2032 (USD MILLION)
  • TABLE 166. ASEAN SPECIALTY PACS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 167. ASEAN SPECIALTY PACS MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 168. ASEAN SPECIALTY PACS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 169. ASEAN SPECIALTY PACS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 170. ASEAN SPECIALTY PACS MARKET SIZE, BY DEPLOYMENT, 2018-2032 (USD MILLION)
  • TABLE 171. ASEAN SPECIALTY PACS MARKET SIZE, BY CLOUD, 2018-2032 (USD MILLION)
  • TABLE 172. GCC SPECIALTY PACS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 173. GCC SPECIALTY PACS MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 174. GCC SPECIALTY PACS MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 175. GCC SPECIALTY PACS MARKET SIZE, BY HARDWARE, 2018-2032 (USD MILLION)
  • TABLE 176. GCC SPECIALTY PACS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 177. GCC SPECIALTY PACS MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 178. GCC SPECIALTY PACS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 179. GCC SPECIALTY PACS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 180. GCC SPECIALTY PACS MARKET SIZE, BY DEPLOYMENT, 2018-2032 (USD MILLION)
  • TABLE 181. GCC SPECIALTY PACS MARKET SIZE, BY CLOUD, 2018-2032 (USD MILLION)
  • TABLE 182. EUROPEAN UNION SPECIALTY PACS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 183. EUROPEAN UNION SPECIALTY PACS MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 184. EUROPEAN UNION SPECIALTY PACS MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 185. EUROPEAN UNION SPECIALTY PACS MARKET SIZE, BY HARDWARE, 2018-2032 (USD MILLION)
  • TABLE 186. EUROPEAN UNION SPECIALTY PACS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 187. EUROPEAN UNION SPECIALTY PACS MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 188. EUROPEAN UNION SPECIALTY PACS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 189. EUROPEAN UNION SPECIALTY PACS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 190. EUROPEAN UNION SPECIALTY PACS MARKET SIZE, BY DEPLOYMENT, 2018-2032 (USD MILLION)
  • TABLE 191. EUROPEAN UNION SPECIALTY PACS MARKET SIZE, BY CLOUD, 2018-2032 (USD MILLION)
  • TABLE 192. BRICS SPECIALTY PACS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 193. BRICS SPECIALTY PACS MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 194. BRICS SPECIALTY PACS MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 195. BRICS SPECIALTY PACS MARKET SIZE, BY HARDWARE, 2018-2032 (USD MILLION)
  • TABLE 196. BRICS SPECIALTY PACS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 197. BRICS SPECIALTY PACS MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 198. BRICS SPECIALTY PACS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 199. BRICS SPECIALTY PACS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 200. BRICS SPECIALTY PACS MARKET SIZE, BY DEPLOYMENT, 2018-2032 (USD MILLION)
  • TABLE 201. BRICS SPECIALTY PACS MARKET SIZE, BY CLOUD, 2018-2032 (USD MILLION)
  • TABLE 202. G7 SPECIALTY PACS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 203. G7 SPECIALTY PACS MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 204. G7 SPECIALTY PACS MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 205. G7 SPECIALTY PACS MARKET SIZE, BY HARDWARE, 2018-2032 (USD MILLION)
  • TABLE 206. G7 SPECIALTY PACS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 207. G7 SPECIALTY PACS MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 208. G7 SPECIALTY PACS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 209. G7 SPECIALTY PACS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 210. G7 SPECIALTY PACS MARKET SIZE, BY DEPLOYMENT, 2018-2032 (USD MILLION)
  • TABLE 211. G7 SPECIALTY PACS MARKET SIZE, BY CLOUD, 2018-2032 (USD MILLION)
  • TABLE 212. NATO SPECIALTY PACS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 213. NATO SPECIALTY PACS MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 214. NATO SPECIALTY PACS MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 215. NATO SPECIALTY PACS MARKET SIZE, BY HARDWARE, 2018-2032 (USD MILLION)
  • TABLE 216. NATO SPECIALTY PACS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 217. NATO SPECIALTY PACS MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 218. NATO SPECIALTY PACS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 219. NATO SPECIALTY PACS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 220. NATO SPECIALTY PACS MARKET SIZE, BY DEPLOYMENT, 2018-2032 (USD MILLION)
  • TABLE 221. NATO SPECIALTY PACS MARKET SIZE, BY CLOUD, 2018-2032 (USD MILLION)
  • TABLE 222. GLOBAL SPECIALTY PACS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 223. UNITED STATES SPECIALTY PACS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 224. UNITED STATES SPECIALTY PACS MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 225. UNITED STATES SPECIALTY PACS MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 226. UNITED STATES SPECIALTY PACS MARKET SIZE, BY HARDWARE, 2018-2032 (USD MILLION)
  • TABLE 227. UNITED STATES SPECIALTY PACS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 228. UNITED STATES SPECIALTY PACS MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 229. UNITED STATES SPECIALTY PACS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 230. UNITED STATES SPECIALTY PACS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 231. UNITED STATES SPECIALTY PACS MARKET SIZE, BY DEPLOYMENT, 2018-2032 (USD MILLION)
  • TABLE 232. UNITED STATES SPECIALTY PACS MARKET SIZE, BY CLOUD, 2018-2032 (USD MILLION)
  • TABLE 233. CHINA SPECIALTY PACS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 234. CHINA SPECIALTY PACS MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 235. CHINA SPECIALTY PACS MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 236. CHINA SPECIALTY PACS MARKET SIZE, BY HARDWARE, 2018-2032 (USD MILLION)
  • TABLE 237. CHINA SPECIALTY PACS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 238. CHINA SPECIALTY PACS MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 239. CHINA SPECIALTY PACS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 240. CHINA SPECIALTY PACS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 241. CHINA SPECIALTY PACS MARKET SIZE, BY DEPLOYMENT, 2018-2032 (USD MILLION)
  • TABLE 242. CHINA SPECIALTY PACS MARKET SIZE, BY CLOUD, 2018-2032 (USD MILLION)